Dbv Technologies S.A. (DBVTF) — SEC Filings
Dbv Technologies S.A. (DBVTF) — 39 SEC filings. Latest: 8-K (Dec 16, 2025). Includes 25 8-K, 6 10-Q, 3 SC 13G/A.
View Dbv Technologies S.A. on SEC EDGAR
Overview
Dbv Technologies S.A. (DBVTF) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Oct 30, 2025: DBV Technologies S.A. filed an 8-K on October 30, 2025, reporting on the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements. The filing also includes Regulation FD disclosures and financial statements and exhibits
Sentiment Summary
Across 39 filings, the sentiment breakdown is: 1 bullish, 3 bearish, 35 neutral. The dominant filing sentiment for Dbv Technologies S.A. is neutral.
Filing Type Overview
Dbv Technologies S.A. (DBVTF) has filed 25 8-K, 6 10-Q, 2 DEF 14A, 2 10-K/A, 1 10-K, 3 SC 13G/A with the SEC between Feb 2024 to Dec 2025.
Filings by Year
Recent SEC Filings (39)
Risk Profile
Risk Assessment: Of DBVTF's 35 recent filings, 3 were flagged as high-risk, 12 as medium-risk, and 20 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | N/A |
| Net Income | -$102.118M |
| EPS | -$0.82 |
| Debt-to-Equity | N/A |
| Cash Position | $69.837M |
| Operating Margin | N/A |
| Total Assets | $110.495M |
| Total Debt | $57.641M |
Industry Context
DBV Technologies operates in the highly competitive and capital-intensive biopharmaceutical sector, focusing on developing treatments for food allergies. The industry is characterized by long development cycles, significant R&D investment, and stringent regulatory hurdles. Success hinges on clinical trial outcomes, regulatory approvals, and effective commercialization strategies.
Top Tags
financials (7) · financial-reporting (6) · 8-K (5) · sec-filing (4) · 10-Q (4) · regulation-fd (3) · operations (3) · Biotechnology (3) · 8-k (3) · biotech (3)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Net Loss | $102.118M | Increased from $90.903M in 2024 for the nine months ended September 30 |
| Cash and Cash Equivalents | $69.837M | Increased from $32.456M at December 31, 2024 |
| Capital Increases | $116.936M | Net cash provided by financing activities for the nine months ended September 30, 2025 |
| Research and Development Expenses | $83.790M | Increased from $70.438M in 2024 for the nine months ended September 30 |
| Accumulated Deficit | $348.301M | As of September 30, 2025, up from $286.375M at December 31, 2024 |
| Inventory Write-downs | $13.931M | For the nine months ended September 30, 2025 |
| Basic/Diluted Net Loss per Share | $0.82 | For the nine months ended September 30, 2025, improved from $0.95 in 2024 |
| Ordinary Shares Outstanding | 136,975,159 | As of September 30, 2025, increased from 102,847,501 at December 31, 2024 |
| Net Loss (Q2 2025) | $25.3M | Slight improvement from $26.1M loss in Q2 2024, indicating ongoing operational costs without revenue. |
| Net Loss (YTD June 30, 2025) | $50.1M | Reduced from $52.5M in the prior year, reflecting continued R&D investment. |
| Fiscal Year End | 2024-12-31 | The period covered by the compensation details in the filing. |
| Filing Date | 20250515 | The date DBV Technologies filed this DEF 14A with the SEC. |
| SEC File Number | 001-36697 | Identifies the company's filings with the SEC |
| Period End Date | 2025-03-31 | Financial reporting period |
| Previous Year End | 2024-12-31 | Comparative financial data |
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Dbv Technologies S.A. (DBVTF)?
Dbv Technologies S.A. has 39 recent SEC filings from Feb 2024 to Dec 2025, including 25 8-K, 6 10-Q, 3 SC 13G/A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of DBVTF filings?
Across 39 filings, the sentiment breakdown is: 1 bullish, 3 bearish, 35 neutral. The dominant sentiment is neutral.
Where can I find Dbv Technologies S.A. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Dbv Technologies S.A. (DBVTF) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Dbv Technologies S.A.?
Key financial highlights from Dbv Technologies S.A.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for DBVTF?
The investment thesis for DBVTF includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Dbv Technologies S.A.?
Executive information for Dbv Technologies S.A. is extracted from SEC filings as they are enriched with AI analysis.
What are the main risk factors for Dbv Technologies S.A. stock?
Of DBVTF's 35 assessed filings, 3 were flagged high-risk, 12 medium-risk, and 20 low-risk.
What are recent predictions and forward guidance from Dbv Technologies S.A.?
Forward guidance and predictions for Dbv Technologies S.A. are extracted from SEC filings as they are enriched.